510(k) device
Am Usa 0.9% Sodium Chloride Flush Syringe
Am USA · Saline, Vascular Access Flush (NGT, Class II) · First FDA decision Jul 14, 2011, newest Jan 30, 2012Vascular access
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
6
Naming "Usa 0.9 Sodium"
MAUDE reports
0
Brand "Usa 0.9 Sodium", since 2015
PubMed studies
0
Mentioning "Usa 0.9 Sodium"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Am Usa 0.9% Sodium Chloride Flush Syringe
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K113555 · Decided Jan 30, 2012 · 60 days after receipt
Device type: Saline, Vascular Access Flush (NGT) · Hospital Medicine & Nursing
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Non-Invasive Peripheral Venous Vascular and Hemodialysis Access StudiesLocal determinationIn effectL35751WPS Insurance CorporationUpdated Feb 20, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Usa 0.9 Sodium", any status and sponsor, newest update first.
- CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUsPivotal-lookingRecruiting
Capsicure, LLCResearch network
NCT07701590 · 147 participants (planned) · Start Jun 22, 2026 · Primary completion Dec 20, 2026
Device: Microlyte®; IP 1: Membrane Wrap - Hydro · For: Wound, Foot; Diabetic Foot Ulcer (DFU); Venus Leg Ulcer
Sites: San Diego, California; Coral Gables, Florida; Miami, Florida · 7 sites in all
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Usa 0.9 Sodium", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NGT
3,043 reports: 2,791 malfunction, 207 injury, 23 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1174-2024 · Started Dec 28, 2023 · Posted by FDA Feb 22, 2024
Reason given: The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.
Cause as FDA categorized it: Under Investigation by firm · Device type: Saline, Vascular Access Flush (NGT)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Usa 0.9 Sodium"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NGT.
- 0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP SyringeBecton, Dickinson and Company · 510(k) 2025
- Praxiject 0.9% NaClMedxl, Inc. · 510(k) 2023
- AMSafe Pre-Filled Normal Saline Flush SyringeAmsino International, Inc. · 510(k) 2022
- 0.9% Sodium Chloride Injection, USP, Pre-filled COP SyringeMedline Industries, Inc. · 510(k) 2019
- 0.9% Sodium Chloride Flush SyringeAm USA · 510(k) 2014
- 0.9% Sodium Chloride Injection Usp Bd Posiflush Flush Syringe, Sf Flush SyringeBecton, Dickinson & CO · 510(k) 2013
- Medefil's Normal Saline I.v. Flush SyringeMedefil, Inc. · 510(k) 2010
- Praxiject SP 0.9% NaClMedxl, Inc. · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.